Osmitrol in Viaflex
"Today the U.S. Food and Drug Administration allowed marketing of the NephroCheck test, a first-of-a-kind laboratory test to help determine if certain critically ill hospitalized patients are at risk of developing moderate to severe acute kidney i"...
Osmitrol Injection in Viaflex
OSMITROL Injection (Mannitol Injection, USP) is contraindicated in patients with:
Well established anuria due to severe renal disease, Severe pulmonary congestion
or frank pulmonary edema, Active intracranial bleeding except during craniotomy,
Progressive renal damage or dysfunction after institution of mannitol therapy, including increasing oliguria and azotemia, and
Progressive heart failure or pulmonary congestion after institution of mannitol therapy.
Last reviewed on RxList: 3/4/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Osmitrol Injection in Viaflex Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.